To surpass the merely adequate, and to accomplish something noteworthy, requires one to take on tasks that are unstated and to solve problems that others may not have even noticed. Depending on the structure of your work environment, there may be...
March
2013
Lack of labeling can be a safety problem, and poor or confusing labels or information signs can be even worse.
March
2013
If you manage to stay afloat long enough, past associations inevitably resurface. At a recent Société de Chimie Industrielle luncheon, I reconnected with a client who I hadn’t seen in almost 30 years. In 1983, I was retained by an investment banker...
March
2013
March
2013
Bioactive implants that combine a medical device with one or more biologic therapeutic agents show promise for the targeted treatment of complex medical conditions. Implantable medical devices, such as stents, grafts, and joint replacements, are...
March
2013
To maintain favorable conditions in the brain, the blood-brain barrier limits mass transfer across brain tissue. However, it also restricts the systemic delivery of compounds to treat neurological disorders. Several treatment alternatives to bypass...
March
2013
Engineered nanoparticles can deliver therapeutic agents to specifically targeted cells and then release those agents in a precisely controlled manner. Improved pharmacokinetic properties, reduced toxicity, and the ability to cross biological barriers are some of the key benefits of this approach.
March
2013
Drugs can be administered by many routes, yet all emerging drug delivery technologies aim to improve drug efficacy, minimize side effects, and reduce the burden of care for patients and physicians.
March
2013
Although you might not associate drug delivery with chemical engineering, the principles of chemical engineering — such as mass and energy balances, transport phenomena, reaction kinetics, and particle technology — are intimately involved in drug...
